New research: One-third in alcohol treatment remain in ‘danger zone’ of anxiety, depression, face higher relapse risk

By

min read

OMAHA, Neb. — Nearly one in three people receiving treatment for alcohol use disorder never escapes the heavy anxiety or depression that often shadows early sobriety, according to new research. Researchers also found that those who remain in that “danger zone” are more likely to relapse, highlighting the need for more targeted mental health care during recovery.

“Early abstinence is a make-or-break period,” said lead author Jennifer Blackford, PhD, of the University of Nebraska Medical Center’s Munroe-Meyer Institute. “If anxiety or depression doesn’t improve quickly, relapse risk may be much higher. The good news is, we can identify these patterns in the first few weeks and act before it’s too late.”

The study tracked more than 1,000 people in alcohol use disorder treatment, measuring anxiety and depression symptoms during the first six weeks. Researchers identified three distinct recovery paths:

  • Low trajectory (70%) — Symptoms started low and resolved rapidly.
  • High trajectory (around 25%) — Symptoms started high but gradually improved.
  • Sustained trajectory (around 5%) — Symptoms stayed high with little change.

Those in the sustained group were more likely to suffer from severe PTSD symptoms and other mental health conditions. Women were more likely than men to fall into the high-symptom depression group, suggesting a possible sex-specific risk.

According to the Centers for Disease Control and Prevention, alcohol use disorder contributes to more than 140,000 deaths each year in the U.S., and more than half of patients relapse within a year despite treatment. Researchers say recognizing persistent anxiety and depression early could allow providers to adjust care — whether through psychotherapy focused on anxiety or medication — to improve outcomes.

The findings, published in Alcohol: Clinical and Experimental Research, are based on de-identified patient data from a large community-based treatment program. The study was supported by the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse.

Recent Headlines

  • DEA launches new ‘Fentanyl Free America’ campaign

    December 4, 2025
    Casey Wonnenberg-King Avatar
  • Prison

    Eighth suspected South Dakota prison overdose death since February

    December 3, 2025
    Casey Wonnenberg-King Avatar
  • Protecting children online: Lawmakers debate new safety bills

    December 2, 2025
    Casey Wonnenberg-King Avatar